TMO · Thermo Fisher Scientific Inc.

$629.59 +0.85 (+0.14%)

Market Cap

$232.47B

369.75M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
10-Q	2026-07-31	2026-06-27
8-K	2026-07-23	—
8-K	2026-05-26	2026-05-20
Investor Event Transcript	2026-05-20	2026-06-30
10-Q	2026-05-01	2026-03-28
8-K	2026-04-23	—
DEF 14A	2026-04-07	2026-05-20
8-K	2026-03-24	—
10-K	2026-02-26	2025-12-31
8-K	2026-02-12	2026-02-09
8-K	2026-01-29	—
8-K	2026-01-12	—
8-K	2025-12-01	2025-11-24
10-Q	2025-10-31	2025-09-27
8-K	2025-10-29	—
8-K	2025-10-22	—
8-K	2025-10-07	—
8-K	2025-09-02	2025-09-01
10-Q	2025-08-01	2025-06-28
8-K	2025-07-23	—
8-K	2025-07-23	—
8-K	2025-05-28	2025-05-21
8-K	2025-05-22	2025-05-21
10-Q	2025-05-02	2025-03-29
8-K	2025-04-23	—
DEF 14A	2025-04-08	2025-05-21
8-K	2025-02-25	—
10-K	2025-02-20	2024-12-31
8-K	2025-02-19	—
8-K	2025-01-30	—
10-Q	2024-11-01	2024-09-28
8-K	2024-10-23	—
10-Q	2024-08-02	2024-06-29
8-K	2024-07-24	—
8-K	2024-07-10	—
8-K	2024-05-24	2024-05-22
10-Q	2024-05-03	2024-03-30
8-K	2024-04-24	—
DEF 14A	2024-04-09	2024-05-22
10-K	2024-02-22	2023-12-31
8-K	2024-01-31	—
8-K	2023-12-05	—
8-K	2023-11-07	—
10-Q	2023-11-03	2023-09-30
8-K	2023-10-25	—
8-K	2023-10-17	—
8-K/A	2023-09-21	2023-07-13
8-K	2023-08-10	—
8-K	2023-08-08	—
10-Q	2023-08-04	2023-07-01

Showing 1–50 of 126 filings

Key facts CIK 97745 CUSIP 883556102 13F (30d) 1901 filings 1826 filers Visit website Investor relations